It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LLY’s FA Score shows that 2 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LLY’s TA Score shows that 4 TA indicator(s) are bullish while OGN’s TA Score has 4 bullish TA indicator(s).
LLY (@Pharmaceuticals: Major) experienced а +4.56% price change this week, while OGN (@Pharmaceuticals: Major) price change was +0.55% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -3.16%. For the same industry, the average monthly price growth was -4.10%, and the average quarterly price growth was +3.76%.
LLY is expected to report earnings on Jan 30, 2025.
OGN is expected to report earnings on Feb 13, 2025.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
LLY | OGN | LLY / OGN | |
Capitalization | 740B | 4.73B | 15,648% |
EBITDA | 8.57B | 1.44B | 597% |
Gain YTD | 39.943 | 14.999 | 266% |
P/E Ratio | 131.13 | 4.64 | 2,828% |
Revenue | 34.1B | 6.26B | 544% |
Total Cash | 2.93B | 693M | 423% |
Total Debt | 25.2B | 8.76B | 288% |
LLY | ||
---|---|---|
OUTLOOK RATING 1..100 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | |
PROFIT vs RISK RATING 1..100 | 4 | |
SMR RATING 1..100 | 17 | |
PRICE GROWTH RATING 1..100 | 58 | |
P/E GROWTH RATING 1..100 | 85 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LLY | OGN | |
---|---|---|
RSI ODDS (%) | 1 day ago72% | 1 day ago64% |
Stochastic ODDS (%) | 1 day ago67% | 1 day ago51% |
Momentum ODDS (%) | 1 day ago59% | 1 day ago57% |
MACD ODDS (%) | 1 day ago37% | 1 day ago71% |
TrendWeek ODDS (%) | 1 day ago70% | 1 day ago67% |
TrendMonth ODDS (%) | 1 day ago50% | 1 day ago66% |
Advances ODDS (%) | 4 days ago71% | 15 days ago67% |
Declines ODDS (%) | 1 day ago52% | 9 days ago71% |
BollingerBands ODDS (%) | 1 day ago70% | 1 day ago67% |
Aroon ODDS (%) | 1 day ago57% | 1 day ago75% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RMIF | 25.37 | N/A | +0.01% |
LHA Risk-Managed Income ETF | |||
DMDV | 23.62 | N/A | N/A |
AAM S& P Developed Markets High Dividend Value ETF | |||
DWUS | 49.13 | -0.15 | -0.30% |
AdvisorShares DW FSM US Core ETF | |||
ETCG | 10.41 | -0.04 | -0.38% |
Grayscale Ethereum Classic Trust (ETC) | |||
IVLU | 27.59 | -0.14 | -0.50% |
iShares Edge MSCI Intl Value Factor ETF |
A.I.dvisor indicates that over the last year, LLY has been loosely correlated with NVS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then NVS could also see price increases.
A.I.dvisor indicates that over the last year, OGN has been loosely correlated with BIIB. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then BIIB could also see price increases.
Ticker / NAME | Correlation To OGN | 1D Price Change % | ||
---|---|---|---|---|
OGN | 100% | +0.19% | ||
BIIB - OGN | 33% Loosely correlated | -1.48% | ||
JNJ - OGN | 27% Poorly correlated | +0.39% | ||
AMRN - OGN | 27% Poorly correlated | +3.33% | ||
AMGN - OGN | 26% Poorly correlated | +0.87% | ||
SNY - OGN | 26% Poorly correlated | -1.22% | ||
More |